The past 25 years have seen remarkable advances in clinical eye care for children in the UK. This has led to both improved outcomes and better patient and family experiences. There have been substantial changes to patient pathways, major advances...
NF2 is a genetic condition caused by mutation in a single gene (NF2 gene) on chromosome 22. The NF2 gene provides instructions to produce a protein called merlin, also known as schwannomin. This protein functions as a tumour suppressor, preventing...
Central retinal vein occlusion (CRVO) is the second most common retinal vascular disease after diabetic retinopathy, and its clinical complexity often intersects with medico-legal scrutiny [1]. Missteps in timely diagnosis, inadequate follow-up or poor documentation can lead to patient harm...
"Please don’t move” is a common phrase I have heard whilst shadowing in theatres as the ophthalmologist contends with the eye of a patient looking around and tilting their head during surgery. As the average corneal diameter is approximately 12–12.5mm...
The demographic time bomb poses the dilemma of how more healthcare can be delivered to the UK’s ageing population without commensurate growth in resources. The Way Forward Project provides a robust resource for clinical centres to better identify and implement...
The new research from eye care nonprofit Orbis International is among the first to look at vision and road safety among public transportation workers in low- and middle-income countries.
‘The times they are a-changin’. The words of this Dylan classic resonate down the decades, and in the light of recent events, speak eloquently to life in 2022. It feels like a lifetime of change has passed since the Eye...
In 2022, leading eye care charity Orbis published research showing that children with poor vision are more likely to suffer with depression, anxiety, low self-esteem and a reduced quality of life.
The Association of Optometrists welcomes the Driver and Vehicle Standards Agency’s latest plans to review how sight tests are administered but urges the implementation of fail-safe visual assessment methods.
Scientists are working on a new device that could lead to a reduction in the number of people who go blind from age-related macular degeneration (AMD).